The Effects of 20 Weeks of Side-Alternating Vibration Therapy on Physical Function, Bone and Muscle Health in Adolescents with Down Syndrome.

The Effects of 20 Weeks of Side-Alternating Vibration Therapy on Physical Function, Bone and Muscle Health in Adolescents with Down Syndrome. Phys Occup Ther Pediatr. 2020 Apr 28;:1-12 Authors: Gusso S, Vesey RM, Derraik JGB, Munns CF, Colle P, Biggs JB, Hofman PL Abstract Aims: To evaluate the effects of side-alternating vibration therapy on physical function and body composition in adolescents with Down syndrome.Methods: Fourteen adolescents (8 males) with Down syndrome (mean ± SD age: 15.5 ± 2.3 years) performed vibration treatment nine minutes daily, four times per week, for 20 weeks on a Galileo vibration platform. Data were collected at baseline and after 20 weeks of intervention. Assessments included six-minute walk test, muscle function (force plate), whole-body dual-energy X-ray absorptiometry and peripheral quantitative computed tomography of the non-dominant tibia.Results: After 20 weeks, participants increased their distance walked in the six-minute walk test (p = 0.009), 2-leg single jump efficiency (p = 0.024) and jump velocity (p = 0.046). Participants also increased their power (p = 0.034) and reduced the time taken during the chair rise test (p 
Source: Physical Therapy - Category: Physiotherapy Authors: Tags: Phys Occup Ther Pediatr Source Type: research

Related Links:

PMID: 32285748 [PubMed - indexed for MEDLINE]
Source: Physical Therapy - Category: Physiotherapy Authors: Tags: Phys Occup Ther Pediatr Source Type: research
rez The ever-growing and widespread use of touch, face, full-body, and 3D mid-air gesture recognition sensors in domestic and industrial settings is serving to highlight whether interactive gestures are sufficiently inclusive, and whether or not they can be executed by all users. The purpose of this study was to analyze full-body gestures from the point of view of user experience using the Microsoft Kinect sensor, to identify which gestures are easy for individuals living with Down syndrome. With this information, app developers can satisfy Design for All (DfA) requirements by selecting suitable gestures from existing ...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
Down syndrome is a common chromosomal abnormality and prenatal screening can inform parents of the risk of their baby having Down syndrome. Little research has examined how decisions regarding both Down syndro...
Source: BMC Pregnancy and Childbirth - Category: OBGYN Authors: Tags: Research article Source Type: research
Inflammatory arthritis in children with Down syndrome (DS) was first described in 1984 and is now termed Down syndrome-associated arthritis (DA). Studies have shown that DA is under-recognized with a 19-month ...
Source: Pediatric Rheumatology - Category: Rheumatology Authors: Tags: Research article Source Type: research
Publication date: September 2020Source: Research in Developmental Disabilities, Volume 104Author(s): Michael S.C. Thomas, Olatz Ojinaga Alfageme, Hana D’Souza, Prachi A. Patkee, Mary A. Rutherford, Kin Y. Mok, John Hardy, Annette Karmiloff-Smith, the LonDownS Consortium
Source: Research in Developmental Disabilities - Category: Disability Source Type: research
Conclusions: Bilateral FOs has a positive immediate impact on gait quality in adolescents with DS, as confirmed by quantitative analysis. FOs prescription is an evidence-based early approach to slow down biomechanical abnormalities and prevent relative symptoms.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
(Istituto Italiano di Tecnologia - IIT) Researchers at IIT-Istituto Italiano di Tecnologia discovered a novel chemical compound, which has the potential to became a new drug for the treatment of core symptoms of brain disorders like Down syndrome and autism. Results are obtained in preclinical models where the new compound ameliorated difficulties in cognitive tasks, social interactions and repetitive behaviors. Researchers aim to create a start-up company in order to further develop this compound and make it a treatment for patients
Source: EurekAlert! - Biology - Category: Biology Source Type: news
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.0c00346
Source: ACS Medicinal Chemistry Letters - Category: Chemistry Authors: Source Type: research
Authors: Salemi M, Marchese G, Cordella A, Cannarella R, Barone C, Salluzzo MG, Calogero AE, Romano C Abstract Trisomy 21, also known as Down Syndrome (DS), is the most common chromosome abnormality and causes intellectual disability. Long non-coding RNA (lncRNA) growth arrest-specific 5 (GAS5), whose differential expression has recently been reported in patients with Klinefelter syndrome, has been addressed to play a role in the development of inflammatory and autoimmune diseases, vascular endothelial cells apoptosis and atherosclerosis, all being common features in patients with DS. Therefore, the aim of this stu...
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
AbstractDown syndrome fits an immunophenotype of combined immunodeficiency with immunodysregulation, manifesting with increased susceptibility to infections, autoimmunity, autoinflammatory diseases, and hematologic malignancies. Qualitative and quantitative alterations in innate and adaptive immunity are found in most individuals with Down syndrome. However, there is substantial heterogeneity and no correlation between immunophenotype and clinical presentation. Previously, it was thought that the immunological changes in Down syndrome were caused by precocious aging. We emphasize in this review that the immune system in Do...
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research
More News: Australia Health | Clinical Trials | CT Scan | DEXA Scan | Down's Syndrome | New Zealand Health | Physical Therapy | Physiotherapy